Skip to content
TaperMD

TaperMD

Pause and Monitor: Approach to reducing medication burden of polypharmacy

  • Taper Guidance
  • Deprescribing Resources
  • About
  • Portal login

Proton Pump Inhibitors (PPI) Deprescribing Resources

Resources

Primary Health Tasmania
  • A guide to deprescribing proton pump inhibitors [PDF]
NSW Therapeutic Advisory Group Inc.
  • Proton Pump Inhibitors (PPIs) [PDF]
References & Relevant Literature
  • Thompson W, Hogel M, Li Y, Thavorn K, O’Donnell D, McCarthy L, Dolovich L Black C, Farrell B. Effect of a proton pump inhibitor deprescribing guideline on drug usage and costs in long-term care. JAMDA, 2016, in press, doi.org/10.1016/j.jamda.2016.04.020.
  • Boghossian TA, Rashid FJ, Welch V, Rojas-Fernandez C, Moayyedi P, Pottie K, Walsh K, Pizzola L, Thompson W, Farrell B. Deprescribing versus continuation of chronic proton pump inhibitor use in adults (protocol). Cochrane Database Syst Rev, 2015; Issue 11, article number CD011969.
  • News
  • Contact us
  • Privacy
  • Cookies Policy
  • Terms
Copyright © 2023 TaperMD. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.